Stabilizing hemoglobin levels: what's new in IV iron and anemia management?
One of the challenges encountered by the nephrology nursing community is how to appropriately stabilize hemoglobin (Hb) levels. Recently, this issue has taken center stage in the anemia management environment, stemming from reports that the majority of patients on hemodialysis are not routinely maintained in an Hb target range of 11 to 12 g/dL and that Hb variability is associated with adverse outcomes. This article will help nephrology nurses better understand the balance between intravenous iron and erythropoiesis-stimulating agents to stabilize Hib levels.
Winthrop-University Hospital, Mineola, NY, USA.
Steven
S
Fishbane
Kristin
K
Larson
Suzann
S
VanBuskirk
D000740:Anemia / Q000517:prevention & control*; D006397:Hematinics / Q000008:administration & dosage* / Q000009:adverse effects; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D007262:Infusions, Intravenous; D007501:Iron / Q000008:administration & dosage*; D017410:Practice Guidelines as Topic; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000188:drug therapy* / Q000451:nursing
D006397:Hematinics; D006454:Hemoglobins; D007501:Iron